n-acetyl-s-farnesylcysteine has been researched along with sq-23377 in 1 studies
Studies (n-acetyl-s-farnesylcysteine) | Trials (n-acetyl-s-farnesylcysteine) | Recent Studies (post-2010) (n-acetyl-s-farnesylcysteine) | Studies (sq-23377) | Trials (sq-23377) | Recent Studies (post-2010) (sq-23377) |
---|---|---|---|---|---|
42 | 0 | 6 | 4,385 | 10 | 493 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kornhauser, R; Stock, JB; Volker, C; Wang, W | 1 |
1 other study(ies) available for n-acetyl-s-farnesylcysteine and sq-23377
Article | Year |
---|---|
Protein prenylcysteine analog inhibits agonist-receptor-mediated signal transduction in human platelets.
Topics: Acetylcysteine; Adenosine Diphosphate; Blood Platelets; Calcium; Collagen; Dose-Response Relationship, Drug; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ionomycin; Methylation; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Protein Prenylation; Proto-Oncogene Proteins p21(ras); Saponins; Signal Transduction; Thrombin | 1993 |